动脉样硬化. 动脉样硬化. 稳定和回归的潜在目标
C J Schwartz1, A J Valente, E A Sprague
1Department of Pathology, University of Texas Health Science Center, San Antonio 78284-7750.
Circulation
|December 1, 1992
概括
动脉硬性斑块回归涉及复杂的生物过程. 需要针对细胞机制和血栓形成的新疗法来补充降脂,以获得更好的结果.
科学领域:
- 心血管研究研究心血管研究
- 动脉样硬化病原体的产生
- 翻译医学是一种翻译医学.
背景情况:
- 动脉硬性斑块的稳定和回归在心血管疾病管理中至关重要.
- 斑块回归是一种动态的过程,受斑块组件的启动,进展,稳定和去除的影响.
- 血管学伪回归可能是血栓溶解,动脉扩张或血管放松的结果,这使评估复杂化.
研究的目的:
- 审查当前对动脉样硬化斑块稳定和回归的理解.
- 为了确定除了降脂之外的新兴治疗点,用于斑块修饰.
- 强调需要针对细胞和分子机制和血栓形成的干预措施.
主要方法:
- 审查关于动脉样硬化的人类和动物研究现有文献.
- 对斑块成分和影响回归的因素的动态平衡的分析.
- 在细胞和分子层面确定潜在的治疗点.
主要成果:
- 降脂疗法显示临床益处,但产生适度的血管学回归.
- 针对细胞机制 (抗氧化剂,胆固醇代谢,光滑肌肉细胞增殖) 的替代性干预正在出现.
- 由于血栓形成的作用,对内皮血栓抵抗和血栓调节的策略至关重要.
结论:
- 目前的降脂方案在实现显著的斑块回归方面存在局限性.
- 针对特定的细胞和分子通路提供了有前途的互补治疗策略.
- 未来的研究必须优先考虑对血栓形成和斑块稳定的干预措施,以改善心血管结果.
相关概念视频
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


